TFS
BIIB icon

Thoroughbred Financial Services’s Biogen BIIB Stock Holding History

Thoroughbred Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-966
Closed -$273K – 337
2021
Q3 		$273K Sell
966
-170
-15% -$55.7K 0.07% 257
2021
Q2 		$393K Buy
+1,136
New +$344K 0.1% 206
2020
Q4 		– Sell
-863
Closed -$244K – 237
2020
Q3 		$244K Buy
+863
New +$241K 0.09% 204
2020
Q2 		– Sell
-809
Closed -$256K – 218
2020
Q1 		$256K Buy
809
+111
+16% +$33.7K 0.09% 199
2019
Q4 		$207K Buy
+698
New +$194K 0.07% 235

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Thoroughbred Financial Services's BIIB Position: Q4 2021 in Review

Thoroughbred Financial Services sold out of Biogen (BIIB) in Q4 2021, closing a stake of 966 shares — an estimated $273K sold.

Thoroughbred Financial Services first reported a position in BIIB in Q4 2019 and held it in 5 quarters. The position peaked at $393K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Thoroughbred Financial Services reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Thoroughbred Financial Services sold 966 Biogen shares in Q4 2021, an estimated $273K.
  • Thoroughbred Financial Services first reported a position in Biogen in Q4 2019 and held it in 5 quarters.
  • Thoroughbred Financial Services's Biogen position peaked at $393K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Thoroughbred Financial Services's 13F filing for Q4 2021, filed 9 Feb 2022.